Health
- Share via
Reuters
Drug giant SmithKline Beecham said Chief Executive Jan Leschly will retire in April, five months earlier than previously planned, in a move some analysts said may open the way to renewed merger talks with Glaxo Wellcome. Leschly will be succeeded by Jean-Pierre Garnier, chief operating officer at the company. During a conference call, Garnier avoided making any direct comment on Glaxo.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
